Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics.
about
The notch ligand JAGGED1 as a target for anti-tumor therapyNotch is a critical regulator in cervical cancer by regulating Numb splicing.Zeylenone, a naturally occurring cyclohexene oxide, inhibits proliferation and induces apoptosis in cervical carcinoma cells via PI3K/AKT/mTOR and MAPK/ERK pathways.Pterostilbene exerts antitumor activity via the Notch1 signaling pathway in human lung adenocarcinoma cells.The Histone Deacetylase Inhibitor Vaproic Acid Induces Cell Growth Arrest in Hepatocellular Carcinoma Cells via Suppressing Notch Signaling.Notch Signaling Activation in Cervical Cancer Cells Induces Cell Growth Arrest with the Involvement of the Nuclear Receptor NR4A2.Emerging biological treatments for uterine cervical carcinoma.Role of Notch signalling pathway in cancer and its association with DNA methylation.The challenge of targeting notch in hematologic malignancies.Cervical cancer stem cells.Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II.Folates Induce Colorectal Carcinoma HT29 Cell Line Proliferation Through Notch1 Signaling.Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells.Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II.Blockage of Notch signaling inhibits the migration and proliferation of retinal pigment epithelial cells.HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II.Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy
P2860
Q21129294-67A01F10-B795-48C1-80AA-AB2E1A75EBC8Q33598695-982E9571-8542-4848-8CB0-C4170E8649A5Q33687272-0C1664F8-3C05-4DB1-A375-EA4F21184D4FQ34720726-1AD1019F-75BD-4E36-B348-1AF1EAABD16CQ36048511-76F39EC6-465D-4825-A221-9EB7348214D4Q37133625-4E3E1CB3-4855-4B19-B48D-B9ACED7DD561Q37540968-D16AE841-AE55-4382-B5B6-CF5A55CE07A5Q38174045-42FDAF62-C8BF-4100-A9B7-C1C535DB65EFQ38222770-A1492DAD-4C27-4C73-9526-6668CD52870BQ38644474-A0DAE6EF-C4DA-4928-83B3-280AFEF89873Q38849324-F0E006DD-0654-4A9E-8051-68FA7FD84CB4Q38895857-355FD28C-FD7D-49A9-BEE9-8069F539BE8AQ42360452-5D7D2130-389D-49C1-919B-5BD4E1A58E78Q45912062-90D027A5-68B7-487C-8EED-50D942D38CDCQ51851924-E3715132-C373-469F-AD03-0B2B90512552Q52728397-4ABE67D3-2B02-4708-AD22-7A0F8A789889Q57072711-B9251E81-8D06-491A-A1D4-4EDA9DF6633F
P2860
Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Notch1-mediated tumor suppress ...... ed SSTR-targeted therapeutics.
@ast
Notch1-mediated tumor suppress ...... ed SSTR-targeted therapeutics.
@en
type
label
Notch1-mediated tumor suppress ...... ed SSTR-targeted therapeutics.
@ast
Notch1-mediated tumor suppress ...... ed SSTR-targeted therapeutics.
@en
prefLabel
Notch1-mediated tumor suppress ...... ed SSTR-targeted therapeutics.
@ast
Notch1-mediated tumor suppress ...... ed SSTR-targeted therapeutics.
@en
P2093
P2860
P1433
P1476
Notch1-mediated tumor suppress ...... ed SSTR-targeted therapeutics.
@en
P2093
Baofeng Jin
David H Coy
Joseph A Fuselier
L Vienna Mackey
Laura G Franko-Tobin
Lichun Sun
Lynsie M Morris
Minqiu Liu
P2860
P304
P356
10.1634/THEONCOLOGIST.2011-0269
P577
2012-01-30T00:00:00Z